Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search

Volume V No. 12 - September 8, 1998

Pathologists, Clin Labs, Pharmacogenomics & PPMs

AT MY AGE, I AM LEARNING THAT PEOPLE TEND TO HOLD ONE OF TWO OPINIONS about me. It seems that I can frequently be considered a doddering old fool who is totally unhip (although I recall an even earlier generation calling it “unhep”). On the other hand, there are those who grant me great respect. […]

To access this post, you must purchase The Dark Report.

Pathologists, Clin Labs, Pharmacogenomics & PPMs Read More »

Pharmacogenomics Is The Coming Wave

CEO SUMMARY: It may be gloom and doom today in the clinical laboratory industry, but long term prospects for diagnostic testing are brightening. Increased understanding of human genetics drives new discoveries about how and why the same drug affects individuals differently. Biotech companies like Oncormed, Inc. are positioning themselves to apply this knowledge to diagnostic

To access this post, you must purchase The Dark Report.

Pharmacogenomics Is The Coming Wave Read More »

Genetic Testing Almost Accented In Market Place

CEO SUMMARY: Advances in molecular and genetic science have generated the first generation of diagnostic assays for clinical use. As these assays reach the public, acceptance is not immediate. Obstacles are many: ethical, cultural, clinical, and economic. Oncormed’s experience during the last five years provides valuable insights about the challenges of being first to the

To access this post, you must purchase The Dark Report.

Genetic Testing Almost Accented In Market Place Read More »

DIANON Shoots At Urocor, Makes Unwelcome Offer

CEO SUMMARY: It pays to know your friends. Last month DIANON Systems announced an unsolicited offer to acquire UroCor. The offer, following months of ongoing discussions between the two companies, was clearly unwelcome at UroCor. Both companies are pushing hard to evolve disease management products from diagnostics testing and compete nationally for urologist referrals  ON

To access this post, you must purchase The Dark Report.

DIANON Shoots At Urocor, Makes Unwelcome Offer Read More »

Veterans Administration Network Restructures Using Partnering, Telepathology

CEO SUMMARY: Economic pressures are forcing even the traditional and staid Veterans Administration to extensively reconfigure its laboratory services. At this year’s Executive War College in New Orleans, participants learned how one eight-hospital VA region consolidated testing around two core labs, entered into a partnership with a commercial laboratory, and used telepathology to serve a

To access this post, you must purchase The Dark Report.

Veterans Administration Network Restructures Using Partnering, Telepathology Read More »

Problems In PPM lndustry Affect Pathology Practices

DURING 1998, THE FINANCIAL WOES of many physician practice management (PPM) companies caught healthcare experts, investors, and financial experts by surprise. Problems with the PPM industry could not come at a worse time for the pathology profession. At the very moment that several pathology-based PPMs are bidding strong prices for selected pathology practices, the PPM

To access this post, you must purchase The Dark Report.

Problems In PPM lndustry Affect Pathology Practices Read More »

September 8, 1998 Intelligence: Late Breaking Lab News

If any one individual was to be credited with creating the modern commercial laboratory organization, it would be Paul Brown, M.D., founder and former Chairman of MetPath, Inc. (now Quest Diagnostics Incorporated). Where is he now? For ten years, he served as a Director for UroCor, Inc. of Oklahoma City. Dr. Brown recently resigned from

To access this post, you must purchase The Dark Report.

September 8, 1998 Intelligence: Late Breaking Lab News Read More »

;